Trial intelligence / Profile preview

Magnesium sulfate for reducing anesthetic use and postoperative pain in spinal fusion surgery

IRCT20230810059108N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of magnesium sulfate in postoperative pain (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Blood pressure, Volume of bleeding during surgery and 3 more. Started Aug 2023; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20230810059108N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230810059108N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call